• Skogflåttencefalitt - med Hilde Skudal
    Oct 30 2024
    Sommeren er på hell, men noen steder i landet er det fremdeles mulig å få flåttbitt. Vi har snakket med overlege og forsker Hilde Skudal om skogflåttencefalitt, eller TBE ("Tick Borne Encephalitis"), en mindre utbredt sykdom enn borrelia - men ikke desto mindre viktig å være oppmerksom på.

    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    24 mins
  • Endokarditt og peroral behandling - med Magnus Rasmussen
    Sep 17 2024

    Endokarditt er en sykdom som oftest krever intravenøs antibiotikabehandling i mange uker. De siste årene har imidlertid flere skandinaviske land innført tablettbehandling som et alternativ - og fra august er dette også kommet inn som et alternativ i de norske retningslinjene. Jørgen og Ingrid snakker med professor og endokardittforsker Magnus Rasmussen fra Lund om både om erfaringer med dette i praksis - og litt også om pågående forskning innen endokardittfeltet.


    Referanse:

    Rasmussen M, Gilje P, Fagman E, Berge A. Bacteraemia with gram-positive bacteria-when and how do I need to look for endocarditis? Clin Microbiol Infect. 2024 Mar;30(3):306-311. doi: 10.1016/j.cmi.2023.08.027. Epub 2023 Sep 1. PMID: 37659693.


    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    24 mins
  • Antibiotika, en fremtidsodyssé - med Oddvar Oppegaard
    Aug 14 2024
    Jørgen, Nikolai og Ingrid får celebert besøk av Pestpostens redaktør Oddvar Oppegaard. Vi benytter anledningen til å kikke i den infeksjonsmedisinske krystallkulen og lære mer om antibiotikautvikling.

    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    42 mins
  • Antibiotika - betalaktamringenes brorskap (eller; mer om virkningsmekanismer)
    Aug 14 2024
    Atter er Jørgen, Ingrid og Nikolai samlet i studio for å snakke løst og fast om antibiotika. Mest løst. I denne episoden tar vi for oss på virkningsmekanismene til de ulike antibiotikagruppene - ingen detaljkunnskap her, men generelt overblikk og romslige metaforer. Velkommen inn i studio med oss!

    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    25 mins
  • A talk - about talking. How our words matter in healthcare. - with Beverley Preater and Paul Garner
    Jul 11 2024
    A talk - about talking - and the importance of communication. Listen to Beverley Preater, experienced MSF-doctor, and professor Paul Garner, share their stories.

    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    41 mins
  • Leishmaniasis
    Jun 14 2024
    Jørgen og Ingrid snakker seg gjennom tropesykdommen leishmaniasis - helt fra sandfluenes hemmelige liv, videre til diagnostikk og behandling. Vi får god hjelp av professor Bjørn Blomberg og doktor Zikre Gebremariam.

    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    45 mins
  • Scepticaemia - helping find meaning in science
    Apr 22 2024

    We meet Paul Garner (prof. emerit. and one of the founding fathers of Cochrane) and Rebecca Kuehn (Cochrane infectious diseases) for a talk about evidence-based medicine, critical appraisal and all things related to how we interpret and find the "truth" within research.


    Resources:

    1.Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2(8):e124.

    2.Garner P, Taylor-Robinson D, Sachdev HS. DEVTA: results from the biggest clinical trial ever. Lancet. 2013;381(9876):1439-41.

    3.Gigerenzer G. Making sense of health statistics. Bull World Health Organ. 2009;87(8):567.

    4.https://www.badscience.net/2010/07/yeah-well-you-can-prove-anything-with-science/

    5.de Souza DK, Thomas R, Bradley J, Leyrat C, Boakye DA, Okebe J. Ivermectin treatment in humans for reducing malaria transmission. Cochrane Database Syst Rev. 2021;6(6):CD013117.

    6.Foy BD, Alout H, Seaman JA, Rao S, Magalhaes T, Wade M, et al. Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial. Lancet. 2019;393(10180):1517-26.

    7.Popp M, Reis S, Schiesser S, Hausinger RI, Stegemann M, Metzendorf MI, et al. Ivermectin for preventing and treating COVID-19. Cochrane Database Syst Rev. 2022;6(6):CD015017.

    8.Hadinegoro SR, Arredondo-Garcia JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, et al. Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. N Engl J Med. 2015;373(13):1195-206.

    9.Dans AL, Dans LF, Lansang MAD, Silvestre MAA, Guyatt GH. Controversy and debate on dengue vaccine series-paper 1: review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs. J Clin Epidemiol. 2018;95:137-9.

    10. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383-94.

    11. https://bestpractice.bmj.com/info/toolkit/learn-ebm/what-is-grade/

    12.Guyatt G, Vist G, Falck-Ytter Y, Kunz R, Magrini N, Schunemann H. An emerging consensus on grading recommendations? ACP J Club. 2006;144(1):A8-9.


    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    34 mins
  • Filarial nematodes (english version)
    Apr 22 2024
    This is the "all-english"-version of the filaria-episode: Pestpodden presents a tropical topic that many of us struggle with understanding: filarial nematodes. Professor Mark Taylor - one of the worlds leading experts on filarial nematodes - guides us through this difficult topic - and presents some breaking research-news at the end of the episode.

    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    53 mins